Biosplice
PrivateLast Round
Series E
4/15/2021
Total Funding Raised
$778M
Momentum Score
25 /100
Company Overview
Biosplice Therapeutics is a biotechnology company specializing in the development of tissue-level therapeutic drugs for osteoarthritis and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biosplice Comps
Public and private peers based on sector, stage, and business model.
Biosplice Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | 4/15/2021 | ||||
| Private Equity | 8/6/2018 | ||||
| Series A | 4/13/2016 |
Key People
Founding team and executive leadership
Biosplice Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Series E |
| Polar Light Ventures | Private Equity |
| Eventide Funds | Series E |
| Ingka Investments | Series A |
| aMoon | Series E |
| Starling Group | Private Equity |
| Vickers Venture Partners | Series A, Private Equity |
Biosplice Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biosplice's valuation, stock price, and market status.
